PAI
IONS icon

Pittenger & Anderson Inc’s Ionis Pharmaceuticals IONS Stock Holding History

Pittenger & Anderson Inc’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100
Closed -$5K – 414
2015
Q3 		$5K Hold
100
– – ﹤0.01% 413
2015
Q2 		$6K Sell
100
-100
-50% -$6.36K ﹤0.01% 392
2015
Q1 		$13K Sell
200
-100
-33% -$6.79K ﹤0.01% 369
2014
Q4 		$19K Sell
300
-50
-14% -$2.47K ﹤0.01% 357
2014
Q3 		$14K Buy
+350
New +$12.4K ﹤0.01% 337

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Pittenger & Anderson Inc's IONS Position: Q4 2015 in Review

Pittenger & Anderson Inc sold out of Ionis Pharmaceuticals (IONS) in Q4 2015, closing a stake of 100 shares — an estimated $5K sold.

Pittenger & Anderson Inc first reported a position in IONS in Q3 2014 and held it in 5 quarters. The position peaked at $19K in Q4 2014. 334 funds tracked by Wall St. Rank hold IONS as of Q4 2015.

  • Pittenger & Anderson Inc reported no remaining Ionis Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 100 Ionis Pharmaceuticals shares in Q4 2015, an estimated $5K.
  • Pittenger & Anderson Inc first reported a position in Ionis Pharmaceuticals in Q3 2014 and held it in 5 quarters.
  • Pittenger & Anderson Inc's Ionis Pharmaceuticals position peaked at $19K in Q4 2014.
  • 334 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2015.

Based on Pittenger & Anderson Inc's 13F filing for Q4 2015, filed 10 Feb 2016.